LENTECHS is a privately-held, clinical-stage, ophthalmic medical device company in Columbus, Ohio dedicated to improving vision at every stage of life through innovative design and breakthrough contact lens technology. LENTECHS is focused on developing a patented, first-of-its-kind line of soft, suspended contact lens designed to deliver exceptional, glasses-like vision at all distances.
Lentechs is focused on the 120 million US patients and 2 billion worldwide living with presbyopia. The majority of these patients wear spectacles but would prefer to wear contact lenses and, among these patients who do wear contact lenses, many do not receive the desired results from currently available technology.
In early 2022, LENTECHS will debut its new generation of soft, suspended contact lens, designed to deliver exceptional, glasses-like vision at all distances. The contact lens is first and foremost, designed to utilize the eye’s anatomy rather than conform to it. Unlike traditional contact lenses, it is suspended behind the upper eyelid, allowing for free, translational (up and down) eye movement, behind the rotationally-stable, centered contact lens. By allowing the eye to freely move behind the contact lens, wearers can access the specific prescription needed for each visual distance correction.
LENTECHS has patented its front-to-back lens innovations designed to deliver unique vision solutions in soft contact lenses.
Founded with optometrist inventors Melissa Bailey, OD, PhD, and Joe Barr, OD, MS, FAAO, LENTECHS has successfully developed core technology licensed from The Ohio State Innovation Foundation.
Question or comments? We want to hear from you.
The statements on this website have not been evaluated by the FDA, and the device is not currently available for purchase or use in the United States.
